[Model studies on virus-induced tumors and their immunological treatment (author's transl)].
After a review of the general biological properties of C-type oncorna viruses, results are presented on the structure of an exogenous murine leukemia virus (FLV) and on the serobiological properties of its structural proteins. Our findings suggested a major role of the viral surface glycoprotein gp71 in immunological defense mechanisms. This was confirmed by vaccination experiments with isolated gp71 in mice. The induced immunity was highly specific and not operative against endogenous murine C-viruses belonging to other serotypes. Surprisingly the latter were found to be activated by the vaccination with gp71 of FLV. In heterologous animal species isolated FLV-gp71 induced the formation of broadly reacting antibodies. They were found to be effective in the therapy of infections with FLV in mice as well as with feline leukaemia virus in cats. Most impressive results were obtained with an antiserum prepared against feline leukaemia virus in a goat. This serum completely suppressed sarcomas induced by infection with feline sarcoma virus.
D000406:AKR murine leukemia virus; D000818:Animals; D000956:Antigens, Viral; D002415:Cats; D005622:Friend murine leukemia virus / Q000648:ultrastructure; D005814:Genes, Viral; D006801:Humans; D007106:Immune Sera; D007116:Immunization, Passive; D009052:Leukemia Virus, Murine; D007942:Leukemia, Experimental / Q000276:immunology*; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009858:Oncogenic Viruses / Q000276:immunology*; D012190:Retroviridae / Q000276:immunology / Q000472:pathogenicity; D005253:Sarcoma Viruses, Feline; D014412:Tumor Virus Infections / Q000276:immunology*; D014764:Viral Proteins / Q000032:analysis
D000956:Antigens, Viral; D007106:Immune Sera; D014764:Viral Proteins
Modellstudien über virusbedingte Tumoren und deren immunologische Behandlung.